免疫检测市场规模、份额及成长分析（按产品、技术、检体、应用、最终用户和地区）－2025-2032 年产业预测

预计到 2023 年免疫检测市场规模将达到 358 亿美元，从 2024 年的 380.6 亿美元成长到 2032 年的 620.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.3%。

全球免疫检测市场正在经历强劲成长，这得益于技术进步、诊断测试需求的增加以及临床诊断、环境测试和生物製药等多样化应用。但这种成长受到检测变异性以及开发新型免疫测量的复杂性和成本等挑战的限制。技术创新需要大量投资，这为市场进入设置了障碍。然而，个人化医疗的日益增长的趋势正在推动免疫测量的使用，并且来自公共和私营部门的增加的研究津贴正在为市场进入创造机会。总体而言，儘管市场面临一定的障碍，但市场扩张的潜力仍然很高，特别是满足不断变化的医疗保健需求和市场动态。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 专利分析

免疫检测市场规模：按产品

• 市场概览
• 试剂和套件
  • ELISA 试剂和套件
  • CLIA 试剂和套件
  • IFA试剂和套件
  • 快速检测试剂和套件
  • ELISpot 试剂和套件
  • 蛋白质印迹试剂和套件
  • 其他试剂和套件
• 分析仪
  • 按类型
  • 开放式系统
  • 封闭式系统
  • 按购买方式
  • 租赁购买
  • 完成购买

免疫检测市场规模：依技术分类

• 市场概览
• ELISA
• 化学冷光免疫检测（CLIA）
• 萤光试验（IFA）
• 快速检测
• 椭圆光斑
• 西方印渍术
• 其他技术

免疫检测市场规模（按检体）

• 市场概览
• 血
• 唾液
• 尿
• 其他标本

免疫检测市场规模：按应用

• 市场概览
• 感染疾病
• 内分泌学
• 肿瘤学
• 骨骼和矿物质疾病
• 心臟病学
• 血液检查
• 自体免疫疾病
• 过敏诊断
• 毒理学
• 新生儿筛检
• 其他用途

免疫检测市场规模（按最终用户划分）

• 市场概览
• 医院和诊所
• 临床实验室
• 製药/生物技术公司和 CRO
• 血库
• 研究与学术研究所
• 居家照护环境

免疫检测市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Thermo Fisher Scientific Inc.（USA）
• Siemens Healthineers AG（Germany）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Bio-Rad Laboratories, Inc.（USA）
• QIAGEN NV（Germany/Netherlands）
• Sysmex Corporation（Japan）
• Merck KGaA（Germany）
• DiaSorin SpA（Italy）
• bioMerieux SA（France）
• QuidelOrtho Corporation（USA）
• Agilent Technologies, Inc.（USA）
• Hologic Inc.（USA）
• PerkinElmer, Inc.（USA）
• Luminex Corporation（USA）
• Autobio Diagnostics Co., Ltd.（China）
• Beckman Coulter, Inc.（USA）
• Randox Laboratories（UK）

结论和建议

Immunoassay Market size was valued at USD 35.8 billion in 2023 and is poised to grow from USD 38.06 billion in 2024 to USD 62.04 billion by 2032, growing at a CAGR of 6.3% during the forecast period (2025-2032).

The global immunoassay market is experiencing robust growth, driven by technological advancements, heightened demand for diagnostic testing, and diverse applications in clinical diagnostics, environmental testing, and biopharmaceuticals. This growth is tempered by challenges such as assay variability and the complexities and costs associated with developing novel immunoassays. Significant investments are essential for innovation, which can create barriers to market entry. However, opportunities are emerging, particularly with the increasing trend toward personalized medicine that boosts the usage of immunoassays, along with rising funding from both private and public sectors for research initiatives. Overall, while the market faces certain hurdles, the potential for expansion remains strong, particularly in response to evolving healthcare needs and market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunoassay Market Segments Analysis

Global Immunoassay Market is segmented by Product, Technology, Specimen, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits and Analyzers. Based on Technology, the market is segmented into ELISA, Chemiluminescence Immunoassay (CLIA), Immunofluorescence assay (IFA), Rapid Tests, ELISpot, Western Blotting and Other Technologies. Based on Specimen, the market is segmented into Blood, Saliva, Urine and Other Specimens. Based on Application, the market is segmented into Infectious Diseases, Endocrinology,Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening and Other Applications. Based on End User, the market is segmented into Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Immunoassay Market

The immunoassay market is being significantly propelled by increased funding from both governmental bodies and organizations aimed at advancing healthcare research and development. This surge in financial support is fostering the creation and enhancement of advanced immunoassay technologies. Additionally, heightened investments from the private sector, particularly in therapeutic and diagnostic research, are further stimulating demand and innovation within the immunoassay field. As a result, the combination of private sector contributions and proactive government initiatives plays a crucial role in driving the growth and evolution of the immunoassay market.

Restraints in the Immunoassay Market

The immunoassay market faces significant constraints in certain developing regions due to inadequate healthcare infrastructure and a lack of awareness regarding immunoassay techniques. This limited understanding hampers the market's growth potential, as there is an increasing need for education and training on these methodologies, which can be both challenging and costly to implement. Additionally, the shortage of skilled professionals capable of interpreting results and effectively operating immunoassay systems further limits the adoption and demand for these technologies. Consequently, these factors collectively impede the overall expansion of the immunoassay market in these areas.

Market Trends of the Immunoassay Market

The immunoassay market is witnessing significant growth, driven by the expanding applications across various sectors. With the increasing prevalence of infectious and chronic diseases, there is a heightened demand for immunoassays for effective disease monitoring and detection. The biopharmaceutical industry particularly fuels this trend, as these assays are essential for therapeutic monitoring and drug development. Additionally, the rising focus on environmental safety has led to a growing need for immunoassays to detect contaminants, further broadening their application scope. As a result, the market is poised for robust growth, reflecting the versatility and critical role of immunoassays in healthcare and environmental contexts.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Immunoassay Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents & Kits
  • ELISA Reagents & Kits
  • CLIA Reagents & Kits
  • IFA Reagents & Kits
  • Rapid Test Reagent & Kits
  • ELISpot Reagent & Kits
  • Western Blot Reagent & Kits
  • Other Reagents & Kits
• Analyzers
  • By Type
  • Open-ended Systems
  • Closed-ended Systems
  • By Purchase Mode
  • Rental Purchase
  • Outright Purchase

Global Immunoassay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• ELISA
• Chemiluminescence Immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Rapid Tests
• ELISpot
• Western Blotting
• Other Technologies

Global Immunoassay Market Size by Specimen & CAGR (2025-2032)

• Market Overview
• Blood
• Saliva
• Urine
• Other Specimens

Global Immunoassay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Diseases
• Endocrinology
• Oncology
• Bone & Mineral Disorders
• Cardiology
• Blood Screening
• Autoimmune Disorders
• Allergy Diagnostics
• Toxicology
• Newborn Screening
• Other Applications

Global Immunoassay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies and CROs
• Blood Banks
• Research & Academic Laboratories
• Home Care Settings

Global Immunoassay Market Size & CAGR (2025-2032)

• North America (Product, Technology, Specimen, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Specimen, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Specimen, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Specimen, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Specimen, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany/Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autobio Diagnostics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations